BIVI

BioVie, Inc. Common Stock

1.27

USD

-0.03

-2.31%

Nov 10, 15:59 UTC -5

Closed

After-Market

1.27

0.00

0.00%

BioVie, Inc. Common Stock (BIVI) Earnings

BIVI Earnings Reports

Positive Surprise Ratio

BIVI beat 8 of 13 last estimates.

62%

Next Report

Date of Next Report

Feb 04, 2027

Estimate for Q2 27 (Revenue/ EPS)

Implied change from Q1 27 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

BioVie, Inc. Common Stock earnings per share and revenue

On Nov 09, 2026, BIVI reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q2 27, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Definium Therapeutics, Inc. Common Shares

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.56

Actual

-$0.46

Surprise

+19.06%

Ocular Therapeutix, Inc.

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.36

Actual

-$0.42

Surprise

-13.54%

Harrow, Inc. Common Stock

Report Date

Nov 09, 2026 For Q3 26

Estimate

$0.22

Actual

$0.12

Surprise

-45.92%

SIGA Technologies Inc.

Report Date

Nov 09, 2026 For Q3 26

Estimate

Actual

-$0.04

Surprise

Protara Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.35

Surprise

+6.17%

Minerva Neurosciences, Inc

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.12

Actual

$1.94

Surprise

+1,629.97%

Tonix Pharmaceuticals Holding Corp.

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$2.40

Actual

-$2.89

Surprise

-20.23%

Cumberland Pharmaceuticals Inc

Report Date

Nov 10, 2026 For Q3 26

Estimate

Actual

-$0.07

Surprise

PMV Pharmaceuticals, Inc

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$0.34

Actual

-$0.28

Surprise

+15.55%

Corbus Pharmaceuticals Holdings, Inc.

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$1.23

Actual

-$1.81

Surprise

-46.07%

FAQ

What were BioVie, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2027?

For Q1 2027, BioVie, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to BioVie, Inc. Common Stock's Q1 2027 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is BioVie, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 04, 2027.

What are the forecasts for BioVie, Inc. Common Stock's next earnings report?

Based on -- analysts, BioVie, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q2 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.